Back
Ikena Oncology Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
36
IKNA
Ikena Oncology
Last Price:
1.69
Seasonality Move:
-6.69%
Sell
30
NBY
NovaBay Pharmaceuticals
Last Price:
0.70
Seasonality Move:
-0.57%
Sell
36
Ikena Oncology (IKNA)
is a Sell
Is Ikena Oncology a Buy, Sell or Hold?
- The current Ikena Oncology [IKNA] share price is $1.68. The Score for IKNA is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- IKNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.70. The Score for NBY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IKNA Stock Price Chart
What is Ikena Oncology's stock price today?
-
The Ikena Oncology share price today is $1.68
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IKNA is experiencing slight buying pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.70
The current trend is relatively stagnant and NBY is experiencing slight selling pressure.
IKNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 43.23 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.69 - 1.73) | Sell |
Bollinger Bands (100): | (1.65 - 1.73) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 51.68 | Buy |
Chaikin Money Flow: | -16346 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.6 - 0.74) | Buy |
Bollinger Bands (100): | (0.27 - 1.51) | Sell |
IKNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.72 | Sell |
20-day SMA: | 1.71 | Sell |
50-day SMA: | 1.71 | Sell |
200-day SMA: | 1.58 | Buy |
8-day EMA: | 1.7 | Sell |
20-day EMA: | 1.71 | Sell |
50-day EMA: | 1.7 | Sell |
200-day EMA: | 1.88 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.72 | Sell |
20-day SMA: | 0.69 | Buy |
50-day SMA: | 0.65 | Buy |
200-day SMA: | 2.39 | Sell |
8-day EMA: | 0.71 | Sell |
20-day EMA: | 0.7 | Buy |
50-day EMA: | 0.74 | Sell |
200-day EMA: | 5.72 | Sell |
Ikena Oncology Earnings Growth & IKNA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $0.08 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
Ikena Oncology Technical Analysis
Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |